Qianling Zhu

机构：Central South University, Xiangya Hospital Central South University

发表论文 10 篇 · 总被引 548 次 · h-index 7

代表论文

• The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells (2017 · Cell Death and Disease · 被引 130)
• PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells (2018 · Journal of Experimental & Clinical Cancer Research · 被引 128)
• UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications (2021 · Cancer Letters · 被引 78)
• Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition (2018 · Oncogene · 被引 63)
• FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness (2018 · Cell Death and Disease · 被引 58)
• USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis (2019 · Journal of Experimental & Clinical Cancer Research · 被引 50)